Scientists hunt for protein clues in common eye diseases
NCT ID NCT07500324
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects fluid and blood samples from 260 people with age-related macular degeneration, diabetic retinopathy, or retinal detachment, plus healthy controls. Researchers will analyze proteins in these samples to identify markers that could help diagnose or track these eye diseases. The goal is to better understand what drives these conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better diagnostic tests or ways to predict how eye diseases will progress.
- What could go wrong
- This is an early-stage study focused on finding biomarkers, not testing a treatment. It may not directly lead to new therapies or benefit participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (AMD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Fondazione G.B.Bietti
RECRUITINGRoma, Italy, 00184, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?
- Can At-Home eye scans personalize wet AMD treatment?
- Silicone-Filled eyes put Eye-Measuring tools to the test
- Can tight blood sugar control protect the eyes? a study uses advanced imaging to find out
- Could the speed of blood sugar drop harm the eyes? a study puts it to the test.
- AI eye doctor: could a computer spot Blindness-Causing diseases faster than humans?